COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,972,081 | +37.9% | 132,979 | +32.6% | 0.08% | +33.9% |
| Q2 2023 | $2,155,426 | -22.4% | 100,299 | -13.3% | 0.06% | -26.3% |
| Q1 2023 | $2,776,291 | +1050.2% | 115,727 | +1012.3% | 0.08% | +985.7% |
| Q4 2022 | $241,373 | -34.1% | 10,404 | -43.9% | 0.01% | -75.9% |
| Q3 2021 | $366,000 | -23.4% | 18,549 | -8.1% | 0.03% | -34.1% |
| Q1 2021 | $478,000 | +220.8% | 20,174 | +78.3% | 0.04% | +238.5% |
| Q2 2019 | $149,000 | -67.2% | 11,316 | -62.3% | 0.01% | -59.4% |
| Q1 2019 | $454,000 | -20.1% | 29,985 | -9.4% | 0.03% | -11.1% |
| Q4 2018 | $568,000 | +12.7% | 33,081 | -3.2% | 0.04% | -5.3% |
| Q3 2018 | $504,000 | -16.1% | 34,192 | +45.3% | 0.04% | -9.5% |
| Q1 2018 | $601,000 | +132.0% | 23,534 | -8.4% | 0.04% | +27.3% |
| Q1 2017 | $259,000 | – | 25,705 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |